Weight Loss Injections in the UK: Cost, Access, and How to Get Them Safely

Mounjaro and Wegovy are genuinely effective medications. The clinical evidence is solid, the weight loss results are significant, and for many people they represent the first treatment that has actually worked. The problem is the price. Private prescriptions for tirzepatide (Mounjaro) and semaglutide (Wegovy) can vary widely between providers, and for a treatment you may need to take long-term to maintain results, that adds up quickly.

This article breaks down what things actually cost, why NHS access is so limited, and what to look for if you're considering going private.

Who Can Get These Medications on the NHS#

NHS funding for Wegovy and Mounjaro is tightly restricted. NICE approved semaglutide (Wegovy) in 2023 for adults with a BMI of 35 or above plus at least one weight-related condition, such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea. Crucially, it's only available through specialist NHS weight management services, not through your GP.

Mounjaro (tirzepatide) received NICE approval in 2024 under similar criteria. The BMI threshold can drop to 30 if certain comorbidities are present, but access still runs through specialist services rather than primary care.

In practice, this leaves a large group of people excluded. Either their BMI falls below the threshold, they don't have a qualifying comorbidity, or they simply can't get a referral quickly enough. NHS specialist weight management services have long waiting lists in many parts of England, and provision varies considerably across regions. Scotland, Wales, and Northern Ireland have their own commissioning decisions, which adds another layer of complexity.

For the majority of adults who could genuinely benefit from these medications, the NHS route is either unavailable or involves a wait that most people aren't willing or able to tolerate.

What Private Treatment Actually Costs#

Private pricing varies between providers, but it is worth looking beyond the headline “from” price. Some providers use introductory offers, discount codes, subscriptions, or lower first-month prices that do not reflect what you will pay as treatment continues or your dose increases.

At Totiva, pricing is kept clear and transparent, with no subscriptions or tie-ins needed to access lower prices.

Current Totiva Wegovy prices are:

• Wegovy 0.25mg: £92.88
• Wegovy 0.5mg: £92.88
• Wegovy 1mg: £92.88
• Wegovy 1.7mg: £143.88
• Wegovy 2.4mg: £188.88

Current Totiva Mounjaro prices are:

• Mounjaro 2.5mg: £136.88
• Mounjaro 5mg: £157.88
• Mounjaro 7.5mg: £207.88
• Mounjaro 10mg: £232.88
• Mounjaro 12.5mg: £248.88
• Mounjaro 15mg: £268.88

These are prescription medications, so you also need to factor in whether a provider charges separate consultation, delivery, or admin fees. Reputable UK online pharmacies, including Totiva, include the clinical assessment within the overall service rather than adding it as a hidden extra.

One thing worth being clear about: these medications don't work short-term. Studies show that when people stop taking GLP-1 receptor agonists, a significant proportion of the weight lost returns within a year. That makes ongoing affordability a genuine clinical concern, not just a financial one. Discontinuing treatment because of cost is a real outcome that affects real patients.

For that reason, the most affordable provider is not always the one with the lowest introductory offer. It is often the one that lets you clearly see what you will pay each month, without relying on short-term discount codes or prices that jump later.

Why Counterfeit and Unregulated Products Are a Serious Risk#

The demand for these medications has created a secondary market of unlicensed and counterfeit products. In 2023 and 2024, the MHRA issued warnings about fake semaglutide circulating in the UK, including compounded versions and products sold through unregistered websites. Some of these contained incorrect doses, unlicensed ingredients, or no active ingredient at all.

This isn't a minor regulatory footnote. Injecting an unverified product carries genuine risks, including contamination, incorrect dosing, and severe side effects without any clinical oversight to manage them.

If you're buying from a UK-based provider, check that they are registered with the General Pharmaceutical Council (GPhC). Legitimate online pharmacies display their GPhC registration number, prescriptions are issued by UK-registered prescribers, and medications come from licensed UK wholesalers. If a website offers these injections without a prescription, or at prices that seem implausibly low, that's a warning sign.

Totiva is GPhC-registered, and all consultations are led by UK pharmacists. Every prescription is reviewed individually before any medication is dispensed. If you want to explore whether you're suitable for treatment, the weight loss consultation takes around five minutes and gives you a clear answer without commitment.

How to Think About Long-Term Affordability#

The honest answer is that for many people, private GLP-1 treatment is a significant financial commitment. A few things can help:

Start at the lowest effective dose. Mounjaro begins at 2.5mg weekly and titrates upward. Wegovy also starts at a lower dose before increasing gradually. Some people achieve meaningful results without needing to reach the highest doses, which keeps costs lower.

Don't skip doses to make a pack last longer. This is a common workaround that reduces effectiveness and disrupts the titration schedule. It's better to discuss with your prescriber whether the current dose is appropriate.

Look for providers with transparent pricing. Hidden consultation fees, auto-renewal schemes, subscriptions, or prices that change without notice are all red flags. Good providers are upfront about what you'll pay each month.

Be careful with introductory offers. A low first-month price can look attractive, but the repeat price matters more. Before starting, check what the medication will cost at each dose, especially if you may need to continue treatment for several months.

Consider whether NHS access might become available to you. If your BMI or health profile changes, or if your GP is willing to make a referral, NHS pathways may open up over time. It's worth revisiting periodically.

The Bigger Picture#

Obesity is classified as a chronic condition by NICE and the NHS, not a lifestyle choice or a matter of willpower. Medications like Mounjaro and Wegovy work by targeting the hormonal pathways that regulate appetite and satiety, which are disrupted in people with obesity. The clinical trial data, including the SURMOUNT-1 trial for tirzepatide and the STEP-1 trial for semaglutide, showed average weight reductions of 15–22% of body weight. These are not trivial results.

The difficulty is that a treatment's effectiveness doesn't automatically translate into accessibility. Until NHS commissioning expands substantially or prices fall with greater competition, many people will need to navigate the private market carefully.

If you're considering treatment and want to understand your options clearly, Totiva's pharmacist-led service is a straightforward place to start. You'll get an honest assessment of which medications might suit you, clear pricing before you begin, and pharmacist-led monitoring over time.